Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.
Vandevoorde K, Ducreux S, Bosch A, Guillaud O, Hervieu V, Chambon-Augoyard C, Poinsot D, André P, Scoazec JY, Robinson P, Boillot O, Dubois V, Dumortier J.
Vandevoorde K, et al. Among authors: scoazec jy.
Liver Transpl. 2018 Aug;24(8):1091-1100. doi: 10.1002/lt.25177.
Liver Transpl. 2018.
PMID: 29665189